Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays

NCT02588326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hypersensitivity

Interventions

DRUG: Mometasone furoate drug formulation (MFF) 1
DRUG: Mometasone furoate drug formulation (MFF) 2

Sponsor

University of Florida

Collaborators

[object Object]
[object Object]